Do gene mutations impact clinical outcome in elderly acute myeloid leukemia (AML) patients?
Is double autologous transplantation in multiple myeloma superior in the age of new agents?
Progress in acute myeloid leukemia treatment – collaborating to develop targeted therapies
The prognostic value of IDH1 and IDH2 in acute myeloid leukemia (AML)
Why do many MM patients relapse after being treated with targeted therapy?